169
Views
1
CrossRef citations to date
0
Altmetric
Case Reports

Progressive supranuclear palsy presenting with hyperkinetic movement disorder and hemiplegic dystonia: a case report

, , , &
Pages 1278-1281 | Received 10 Aug 2019, Accepted 05 Feb 2020, Published online: 05 Mar 2020

References

  • Massey LA, Jäger HR, Paviour DC, et al. The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy. Neurology. 2013;80(20):1856–1861.
  • Weng R, Wei X, Yu B, et al. Combined measurement of plasma cystatin C and low-density lipoprotein cholesterol: a valuable tool for evaluating progressive supranuclear palsy. Parkinsonism Relat Disord. 2018;52:37–42.
  • Chaal S, Rowe J, Scotton W. Case study of pathologically proven progressive supranuclear palsy (PSP) presenting with prominent chorea. J Neurol Sci. 2015;357:e260–e261.
  • Barclay CL, Lang AE. Dystonia in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. 1997;62(4):352–356.
  • Ishii N, Mochizuki H, Miyamoto M, et al. 18F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging evaluation of chorea. Neurol Int. 2018; 10(3):7780.
  • Karbe H, Holthoff VA, Rudolf J, et al. Positronemission tomography demonstrates frontal cortex and basal ganglia hypometabolism in dystonia. Neurology. 1992;42(8):1540–1544.
  • Lee MS, Marsden CD. Movement disorders following lesions of the thalamus or subthalamic region. Mov Disord. 1994;9(5):493–507.
  • Ghika J, Ghika-Schmid F, Bogousslasvky J. Parietal motor syndrome: a clinical description in 32 patients in the acute phase of pure parietal strokes studied prospectively. Clin Neurol Neurosurg. 1998;100(4):271–282.
  • Xie F, Gao X, Yang W, et al. Advances in the research of risk factors and prodromal biomarkers of Parkinson’s disease. ACS Chem Neurosci. 2019;10(2):973–990.
  • Hoglinger GU, Respondek G, Stamelou M, et al. Movement disorder society-endorsed PSPSG. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord. 2017;32:853–864.
  • Amtage F, Hellwig S, Kreft A, et al. Neuronal correlates of clinical asymmetry in progressive supranuclear palsy. Clin Nucl Med. 2014;39(4):319–325.
  • Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(9):2456–2477.
  • Kobylecki C, Jones M, Thompson JC, et al. Cognitive-behavioural features of progressive supranuclear palsy syndrome overlap with frontotemporal dementia. J Neurol. 2015;262(4):916–922.
  • Leuzy A, Chiotis K, Lemoine L, et al. Tau PET imaging in neurodegenerative tauopathies-still a challenge. Mol Psychiatry. 2019; 24(8):1112–1134.
  • Gabor G, Kovacs JRM, Horvath S, et al. TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. Mov Disord. 2009;24:1843–1847.
  • Melissa J, Armstrong IL, Lang AE, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80(5):496–503.
  • Grimm MJ, Respondek G, Stamelou M, et al. How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy. Mov Disord. 2019;34(8):1228–1232.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.